Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors

Details for Australian Patent Application No. 2006229672 (hide)

Owner IRM LLC

Inventors Pei, Wei; Michellys, Pierre-Yves; Mak, Chi Chung

Agent Davies Collison Cave

Pub. Number AU-B-2006229672

PCT Pub. Number WO2006/104594

Priority 60/656,861 25.02.05 US

Filing date 16 February 2006

Wipo publication date 5 October 2006

Acceptance publication date 11 December 2008

International Classifications

C07D 263/00 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/104594 Priority application(s): WO2006/104594

11 December 2008 Application Accepted

  Published as AU-B-2006229672

8 January 2009 Corrigenda

  Applications Accepted - Name Index Under the name IRM LLC, Application No. 2006229672, under INID (72), correct the co-inventor name to read Mak, Chi Ching

9 April 2009 Standard Patent Sealed

8 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006229687-Isolated myeloid-like bone marrow cell populations and methods of treatment therewith

2006229666-Flow-through cosmetic applicator package